Joignez-vous à nous et participez à l’élucidation de plusieurs cas patients atteints de diabète de type 2 souffrant d’une affection rénale à divers degrés.
BACK15h00 - 16h00 MST
À la fin de cette activité d’apprentissage, les participants seront mieux en mesure de :
- Reconnaître l’importance de la protection rénale et cardiovasculaire (CV) chez les patients atteints de diabète de type 2
- Optimiser les stratégies de protection rénale et CV chez les patients atteints de diabète de type 2
- Personnaliser la prise en charge du diabète de type 2 en fonction des caractéristiques et des affections comorbides des patients
University of British Columbia
Past President American Association of
Clinical Endocrinologists (AACE) Canada Chapter
Columnist, Medscape Diabetes and Endocrinology
Vancouver, BC
Dr. Akshay Jain is the first Canadian physician to be triple board-certified by the American Boards in Endocrinology, Internal Medicine and Obesity Medicine.
He trained in Internal Medicine at Rochester, New York, where he became the only 4- time winner of the prestigious Rochester Academy of Medicine Award. He completed his Fellowship in Endocrinology at Harbor UCLA in Los Angeles, California. He holds the distinction of being the youngest physician to sit on the Board of Directors of the American Association of Clinical Endocrinologists. He is the Past President of the Canadian Chapter of the American Association of Clinical Endocrinologists.
He is the first North American physician to win the prestigious Etzwiler Diabetes Scholarship at the International Diabetes Center and Mayo Clinic in MN, USA. In 2017, he was awarded the Rising Star of Diabetes Award at the International Symposium on Diabetes.
In 2020, he became the only non-American physician to feature on Medscape’s list of 25 Top Rising Stars of Medicine.
He is fluent in 6 languages including English, Hindi, Gujarati, Marathi, Marwari and Urdu. He is a renowned educator and has spoken at over 700 medical conferences/events across the world till date. His clinical interests include diabetes, obesity, thyroid disorders and osteoporosis.
Trillium Health Partners
Investigator, Institute for Better Health
Hypertension Specialist (ASH), Mississauga Hypertension Clinic
Clinical Lecturer, University of Toronto
Toronto, ON
Dr. Louis Girard joined the Division of Nephrology at the University of Calgary in July of 2010. He is a Nephrologist and Clinical Associate Professor. Within the Division of Nephrology, Dr. Girard focuses on clinical immunology and infectious diseases in chronic kidney disease patients. He is the medical director of the Glomerulonephritis Clinic and the Medical Director of Apheresis. Furthermore, he has developed a multi-disciplinary rare diseases clinic that operates out of the Southern Alberta Renal Program. In addition to patients with GN/Vasculitis, this clinic focuses on patients with complement dysregulation, Tuberous Sclerosis and ADPKD. Dr. Girard has a strong clinical research interest. He is currently the local primary investigator on numerous global trials in glomerulonephritis and vasculitis. Dr. Girard has a strong commitment to education and has won numerous awards for his teaching contributions at all levels of medical training.